These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15850275)

  • 21. [Hepatitis C in hemophiliacs].
    Franchini M; Capra F; Veneri D; Lo Cascio G; de Maria E; Manzato F; Lippi G; Gandini G
    Recenti Prog Med; 2004 Jan; 95(1):30-4. PubMed ID: 15032339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?'.
    Matthews G; Dore G
    AIDS; 2003 Dec; 17(18):2675-6. PubMed ID: 14685063
    [No Abstract]   [Full Text] [Related]  

  • 23. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
    Degos F
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S57-65. PubMed ID: 9161515
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
    Tang J; Kaslow RA
    Pharmacogenomics J; 2004; 4(3):171-4. PubMed ID: 15069460
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of hepatitis C virus infection.
    Kew M; François G; Lavanchy D; Margolis H; Van Damme P; Grob P; Hallauer J; Shouval D; Leroux-Roels G; Meheus A;
    J Viral Hepat; 2004 May; 11(3):198-205. PubMed ID: 15117321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
    Yang J; Rao HY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naives, nonresponders, relapsers: who is there left to treat?
    Desai AP; Reau N
    Clin Liver Dis; 2011 Aug; 15(3):483-95. PubMed ID: 21867932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hepatitis C].
    Schrumpf E; Bjøro K; Bell H; Harthug S; Hellum KB; Myrvang B; Maeland A; Ritland S
    Tidsskr Nor Laegeforen; 1996 Jun; 116(15):1792-4. PubMed ID: 8693463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A general approach to the management of chronic hepatitis C.
    Dove LM
    Gastroenterol Clin North Am; 2004 Sep; 33(3):463-77, vii. PubMed ID: 15324938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.
    Lagging M; Wejstål R; Norkrans G; Karlström O; Aleman S; Weiland O; Castedal M; Josephson F;
    Infect Dis (Lond); 2016 Apr; 48(4):251-261. PubMed ID: 26624849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and treatment of hepatitis C virus recurrence after liver transplantation.
    Garcia-Retortillo M; Forns X
    J Hepatol; 2004 Jul; 41(1):2-10. PubMed ID: 15246200
    [No Abstract]   [Full Text] [Related]  

  • 32. [The general practitioner facing hepatitis C].
    Adler M
    Rev Med Brux; 2004 Sep; 25(4):A404-9. PubMed ID: 15516079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural History and Management of Hepatitis C in Children: 25 Years Experience of a Reference Center in Northern Italy.
    Musto F; Stracuzzi M; Crivellaro E; Rubinacci V; Cibarelli A; Porro C; Ghidoni E; Zuccotti GV; Giacomet V
    Pediatr Infect Dis J; 2024 Sep; 43(9):813-818. PubMed ID: 38753999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis C in 2020: from the therapeutic victory over the virus C to the effort on screening].
    Warling O; Delwaide J
    Rev Med Liege; 2020 May; 75(5-6):366-368. PubMed ID: 32496681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Hansen KR; Kjærgaard J; Kvistgaard H; Grosen D; Holm M; Gerstoft J; Nordly S; Helt TW; Christensen VB
    Ugeskr Laeger; 2024 Jan; 186(1):. PubMed ID: 38235776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future.
    Wong JB
    Hepatology; 2002 Jul; 36(1):252-4. PubMed ID: 12085373
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C treatment – yesterday, tomorrow and ….
    Weitzel C
    Med Monatsschr Pharm; 2017 Apr; 40(4):147-50. PubMed ID: 29952162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is splenectomy a cause of antiviral treatment failure in hepatitis C virus infection?
    Paraná R; Codes L; Andrade Z
    Hepatology; 2001 May; 33(5):1340. PubMed ID: 11343268
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment and prevention of hepatitis C--progress and challenges. The Danish Society of Hepatology].
    Bukh J; Christensen E; Krogsgaard K
    Ugeskr Laeger; 2003 Mar; 165(12):1233. PubMed ID: 12701283
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hepatitis C virus infection--is there progress?
    Ruef C
    Infection; 2005 Feb; 33(1):1. PubMed ID: 15750751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.